Q-922

N/A

Report date: 2025/01/26 19:29:19
NME

Base Information

Drug NameQ-922
Drug Alias Namemutant K-Ras/vascular endothelial growth factor inhibitors (Medicon)Q-922
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionV-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog inhibitorsVascular endothelial growth factor receptor antagonists
TargetsVascular endothelial growth factor receptorGTPase KRas
Therapy Area/IndicationsOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMedicon Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesMedicon Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsOvarian Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A